SEAT - NASDAQ
Vivid Seats Inc.
$8.72
-7.4%Vivid Seats Inc. operates as an online secondary marketplace for tickets in the United States and Canada. The company operates in two segments, Marketplace and Resale. The Marketplace segment acts as an intermediary between event ticket buyers and sellers; processes ticket sales on its website and mobile applications through its distribution partners; and sells tickets for live sports, concerts, and theater shows, and other live events. This segment offers Skybox, a proprietary enterprise resource planning tool that helps ticket sellers manage ticket inventories, adjust pricing, and fulfill orders across multiple ticket resale marketplaces. The Resale segment acquires tickets to resell on secondary ticket marketplaces; and provides internal research and development support for Skybox and to deliver seller software and tools. The company was founded in 2001 and is headquartered in Chicago, Illinois.
At a Glance
Live SnapshotVivid Seats Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Vivid Seats Inc. Income Statement
SEAT • NASDAQ
| Vivid Seats Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
570.8M | 775.6M | 712.9M | 600.3M | 443M | 35.1M | 468.9M | |
GROSS PROFIT | |||||||
(222.8M) | (201.9M) | (182.2M) | (140.5M) | (90.6M) | (24.7M) | (106M) | |
347.9M | 573.7M | 530.7M | 459.8M | 352.4M | 10.4M | 362.9M | |
OPERATING INCOME | |||||||
(389.7M) | (531.5M) | (449.4M) | (381.7M) | (275.9M) | (726.4M) | (372.9M) | |
(404.4M) | (479.8M) | (427.2M) | (376M) | (273.5M) | (104.3M) | (279.8M) | |
-41.8M | 42.2M | 81.3M | 78.1M | 76.6M | -716M | -9.9M | |
PRE-TAX INCOME | |||||||
(23.7M) | (23.2M) | (13.5M) | (12.9M) | (58.2M) | (57.5M) | (41.5M) | |
-23.7M | -23.2M | -13.5M | -12.9M | -58.2M | -57.5M | -41.5M | |
-14.7M | (51.7M) | (22.1M) | (5.7M) | (2.3M) | (622.1M) | (93.1M) | |
-610.3M | -19.5M | -10.4M | -8.9M | -95.4M | -58.2M | -43.9M | |
-652.1M | 22.7M | 70.9M | 69.2M | -18.8M | -774.2M | -53.8M | |
NET INCOME | |||||||
(69.4M) | (8.4M) | -42.2M | -1.6M | (304K) | (0.0) | (41.5M) | |
-429.3M | 9.4M | 74.5M | 28.7M | -16.1M | -774.2M | -95.3M |
SEC Filings
SEAT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 27, 2026 | June 09, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 20, 2026 | January 14, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 30, 2025 | December 19, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | October 31, 2025 | 2025 | |
8-K/A 8-K/A 2025 (Amended) N/A | October 23, 2025 | October 19, 2025 | 2025 |
Related Guides
Continue your SEAT research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.